TWD 66.9
(1.21%)
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2023 | 2.04 Billion TWD | -16.87% |
2022 | 2.38 Billion TWD | -13.72% |
2021 | 2.76 Billion TWD | 1.61% |
2020 | 2.71 Billion TWD | -6.76% |
2019 | 2.91 Billion TWD | 10.75% |
2018 | 2.63 Billion TWD | 20.52% |
2017 | 2.18 Billion TWD | 6.38% |
2016 | 2.05 Billion TWD | 10.14% |
2015 | 1.86 Billion TWD | 0.96% |
2014 | 1.84 Billion TWD | 9.1% |
2013 | 1.69 Billion TWD | 0.74% |
2012 | 1.68 Billion TWD | 5.89% |
2011 | 1.58 Billion TWD | 11.73% |
2010 | 1.42 Billion TWD | -5.9% |
2009 | 1.5 Billion TWD | 330.38% |
2008 | 350.66 Million TWD | 0.0% |
2006 | 1.27 Billion TWD | 19.9% |
2005 | 1.06 Billion TWD | 0.0% |
Year | Operating Expenses | Operating Expenses Growth |
---|---|---|
2024 Q2 | 529.74 Million TWD | 6.41% |
2024 Q1 | 497.83 Million TWD | -1.28% |
2023 Q4 | 504.28 Million TWD | -6.32% |
2023 FY | 1.98 Billion TWD | -16.87% |
2023 Q1 | 487.39 Million TWD | -2.31% |
2023 Q2 | 503.45 Million TWD | 3.3% |
2023 Q3 | 538.31 Million TWD | 6.92% |
2022 Q3 | 488.54 Million TWD | -31.6% |
2022 FY | 2.38 Billion TWD | -13.72% |
2022 Q1 | 681.77 Million TWD | -4.64% |
2022 Q2 | 714.2 Million TWD | 4.76% |
2022 Q4 | 498.93 Million TWD | 2.13% |
2021 Q2 | 692.6 Million TWD | 7.29% |
2021 Q3 | 709.52 Million TWD | 2.44% |
2021 FY | 2.76 Billion TWD | 1.61% |
2021 Q4 | 714.91 Million TWD | 0.76% |
2021 Q1 | 645.56 Million TWD | -10.57% |
2020 Q2 | 686.46 Million TWD | 10.1% |
2020 Q4 | 721.87 Million TWD | 5.08% |
2020 Q3 | 686.98 Million TWD | 0.08% |
2020 Q1 | 623.49 Million TWD | -16.75% |
2020 FY | 2.71 Billion TWD | -6.76% |
2019 Q2 | 730.05 Million TWD | 13.15% |
2019 Q4 | 748.96 Million TWD | -5.39% |
2019 FY | 2.91 Billion TWD | 10.75% |
2019 Q1 | 645.21 Million TWD | -11.19% |
2019 Q3 | 791.63 Million TWD | 8.43% |
2018 Q2 | 629.49 Million TWD | 4.81% |
2018 FY | 2.63 Billion TWD | 20.52% |
2018 Q3 | 676.13 Million TWD | 7.41% |
2018 Q1 | 600.61 Million TWD | -4.82% |
2018 Q4 | 726.55 Million TWD | 7.46% |
2017 Q1 | 498.43 Million TWD | -0.93% |
2017 Q2 | 527.9 Million TWD | 5.91% |
2017 Q4 | 631.02 Million TWD | 19.71% |
2017 FY | 2.18 Billion TWD | 6.38% |
2017 Q3 | 527.11 Million TWD | -0.15% |
2016 Q1 | 511.69 Million TWD | 9.48% |
2016 Q4 | 503.13 Million TWD | -1.95% |
2016 Q3 | 513.14 Million TWD | -2.36% |
2016 FY | 2.05 Billion TWD | 10.14% |
2016 Q2 | 525.57 Million TWD | 2.71% |
2015 FY | 1.86 Billion TWD | 0.96% |
2015 Q1 | 456.74 Million TWD | -5.66% |
2015 Q2 | 455.42 Million TWD | -0.29% |
2015 Q3 | 484.86 Million TWD | 6.46% |
2015 Q4 | 467.4 Million TWD | -3.6% |
2014 Q3 | 458.8 Million TWD | -2.75% |
2014 Q2 | 471.75 Million TWD | 9.19% |
2014 FY | 1.84 Billion TWD | 9.1% |
2014 Q4 | 484.12 Million TWD | 5.52% |
2014 Q1 | 432.04 Million TWD | 5.53% |
2013 FY | 1.69 Billion TWD | 0.74% |
2013 Q1 | 402.37 Million TWD | -5.2% |
2013 Q3 | 435.71 Million TWD | -2.14% |
2013 Q2 | 445.23 Million TWD | 10.65% |
2013 Q4 | 409.4 Million TWD | -6.04% |
2012 Q2 | 436.15 Million TWD | 16.67% |
2012 FY | 1.68 Billion TWD | 5.89% |
2012 Q1 | 373.83 Million TWD | -12.26% |
2012 Q4 | 424.45 Million TWD | -4.8% |
2012 Q3 | 445.85 Million TWD | 2.22% |
2011 Q3 | 400.09 Million TWD | -46.85% |
2011 Q2 | 752.71 Million TWD | 9466.78% |
2011 Q1 | 7.86 Million TWD | -99.45% |
2011 FY | 1.58 Billion TWD | 11.73% |
2011 Q4 | 426.06 Million TWD | 6.49% |
2010 Q2 | - TWD | 0.0% |
2010 FY | 1.42 Billion TWD | -5.9% |
2010 Q4 | 1.42 Billion TWD | 0.0% |
2010 Q1 | - TWD | 0.0% |
2010 Q3 | - TWD | 0.0% |
2009 FY | 1.5 Billion TWD | 330.38% |
2008 FY | 350.66 Million TWD | 0.0% |
2006 FY | 1.27 Billion TWD | 19.9% |
2005 FY | 1.06 Billion TWD | 0.0% |
Name | Operating Expenses | Operating Expenses Difference |
---|---|---|
Grape King Bio Ltd | 6.03 Billion TWD | 66.094% |
Standard Chem & Pharm CO., LTD. | 1.46 Billion TWD | -39.696% |
Maywufa Company Ltd. | 854.37 Million TWD | -139.673% |
ScinoPharm Taiwan, Ltd. | 901.49 Million TWD | -127.144% |
Lotus Pharmaceutical Co., Ltd. | 4.48 Billion TWD | 54.301% |
LIWANLI Innovation Co., Ltd. | 54.86 Million TWD | -3632.184% |
PhytoHealth Corporation | 67.64 Million TWD | -2927.216% |
SCI Pharmtech, Inc. | 190.02 Million TWD | -977.606% |
Formosa Laboratories, Inc. | 1.24 Billion TWD | -64.032% |
PharmaEssentia Corporation | 4.49 Billion TWD | 54.446% |
Bora Pharmaceuticals Co., LTD. | 1.74 Billion TWD | -17.542% |